Kryvyi Rih

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Lung cancer4 trials
• Ovarian cancer1 trial
• Sarcoma1 trial

Phase

• Phase 34 trials
• Phase 41 trial

Status

• Active, not recruiting3 trials
• Completed2 trials

Lead sponsor

• AstraZeneca5 trials

Running trials

• Active, not recruiting

  D9319C00001- 1L OC Mono Global RCT

  NCT04884360· Phase 3· AstraZeneca· Source

• Active, not recruiting

  Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)

  NCT03043872· Phase 3· AstraZeneca· Source

• Active, not recruiting

  Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC

  NCT01933932· Phase 3· AstraZeneca· Source

Closed trials

• Completed

  Durvalumab Long-Term Safety and Efficacy Study

  NCT04078152· Phase 4· AstraZeneca· Source

• Completed

  AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

  NCT02296125· Phase 3· AstraZeneca· Source